{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:03:24Z","timestamp":1762430604986},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T00:00:00Z","timestamp":1323129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T00:00:00Z","timestamp":1323129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1038\/pcan.2011.62","type":"journal-article","created":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T11:39:40Z","timestamp":1323171580000},"page":"202-209","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme"],"prefix":"10.1038","volume":"15","author":[{"given":"M","family":"Nomura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Miyakubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,6]]},"reference":[{"key":"BFpcan201162_CR1","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","volume":"360","author":"FH Schr\u00f6der","year":"2009","unstructured":"Schr\u00f6der FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360: 1320\u20131328.","journal-title":"N Engl J Med"},{"key":"BFpcan201162_CR2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S1470-2045(10)70146-7","volume":"11","author":"J Hugosson","year":"2010","unstructured":"Hugosson J, Carlsson S, Aus G, Bergdahl S, Khatami A, Lodding P et al. Mortality results from the G\u00f6teborg randomised population-based prostate-cancer screening trial. Lancet Oncol 2010; 11: 725\u2013732.","journal-title":"Lancet Oncol"},{"key":"BFpcan201162_CR3","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/S0022-5347(01)63771-6","volume":"159","author":"AR Vashi","year":"1998","unstructured":"Vashi AR, Wojno KJ, Gillespie B, Oesterling JE . A model for the number of cores per prostate biopsy based on patient age and prostate gland volume. J Urol 1998; 159: 920\u2013924.","journal-title":"J Urol"},{"key":"BFpcan201162_CR4","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1002\/cncr.10941","volume":"95","author":"K Ito","year":"2002","unstructured":"Ito K, Ohi M, Yamamoto T, Miyamoto S, Kurokawa K, Fukabori Y et al. The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with prostate specific antigen levels of 4.1\u201310.0\u2009ng\/ml. Cancer 2002; 95: 2112\u20132119.","journal-title":"Cancer"},{"key":"BFpcan201162_CR5","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0090-4295(99)00213-7","volume":"54","author":"JA Eastham","year":"1999","unstructured":"Eastham JA, May R, Robertson JL, Sartor O, Kattan MW . Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4\u2009ng\/ml. Urology 1999; 54: 709\u2013713.","journal-title":"Urology"},{"key":"BFpcan201162_CR6","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1097\/01.ju.0000158039.94467.5d","volume":"173","author":"PI Karakiewicz","year":"2011","unstructured":"Karakiewicz PI, Benayoun S, Kattan MW, Perrotte P, Valiquette L, Scardino PT et al. Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen. J Urol 2011; 173: 1930\u20131934.","journal-title":"J Urol"},{"key":"BFpcan201162_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.urology.2005.07.040","volume":"67","author":"H Suzuki","year":"2006","unstructured":"Suzuki H, Komiya A, Kamiya N, Imamoto T, Kawamura K, Miura J et al. Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients. Urology 2006; 67: 131\u2013136.","journal-title":"Urology"},{"key":"BFpcan201162_CR8","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1200\/JCO.2007.10.6450","volume":"25","author":"RK Nam","year":"2007","unstructured":"Nam RK, Toi A, Klotz LH, Trachtenberg J, Jewett MA, Appu S et al. Assessing individual risk for prostate cancer. J Clin Oncol 2007; 25: 3582\u20133588.","journal-title":"J Clin Oncol"},{"key":"BFpcan201162_CR9","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.eururo.2006.08.039","volume":"52","author":"FK Chun","year":"2007","unstructured":"Chun FK, Briganti A, Graefen M, Montorsi F, Porter C, Scattoni V et al. Development and validation of an extended 10-core biopsy nomogram. Eur Urol 2007; 52: 436\u2013445.","journal-title":"Eur Urol"},{"key":"BFpcan201162_CR10","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/j.1442-2042.2008.02183.x","volume":"15","author":"S Kawakami","year":"2008","unstructured":"Kawakami S, Koga F, Fujii Y, Saito K, Yamamoto S, Tatokoro M et al. History of malignancy is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram. Int J Urol 2008; 15: 1055\u20131060.","journal-title":"Int J Urol"},{"key":"BFpcan201162_CR11","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.eururo.2008.01.017","volume":"54","author":"S Kawakami","year":"2008","unstructured":"Kawakami S, Numao N, Okubo Y, Koga F, Yamamoto S, Saito K et al. Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy. Eur Urol 2008; 54: 610\u2013611.","journal-title":"Eur Urol"},{"key":"BFpcan201162_CR12","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/j.1442-2042.2008.02058.x","volume":"15","author":"K Kawamura","year":"2008","unstructured":"Kawamura K, Suzuki H, Kamiya N, Imamoto T, Yano M, Miura J et al. Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10\u2009ng\/ml. Int J Urol 2008; 15: 598\u2013603.","journal-title":"Int J Urol"},{"key":"BFpcan201162_CR13","first-page":"2487","volume":"28","author":"H Ide","year":"2007","unstructured":"Ide H, Yasuda M, Nishio K, Saito K, Isotani S, Kamiyama Y et al. Development of a nomogram for predicting high-grade prostate cancer on biopsy: the significance of serum testosterone levels. Anticancer Res 2007; 28: 2487\u20132492.","journal-title":"Anticancer Res"},{"key":"BFpcan201162_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eururo.2009.08.011","volume":"57","author":"V Scattoni","year":"2010","unstructured":"Scattoni V, Raber M, Abdollah F, Roscigno M, Deh\u00f2 F, Angiolilli D et al. Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy. Eur Urol 2010; 57: 1\u20138.","journal-title":"Eur Urol"},{"key":"BFpcan201162_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.eururo.2009.08.025","volume":"57","author":"MJ Roobol","year":"2010","unstructured":"Roobol MJ, Steyerberg EW, Kranse R, Wolters T, van den Bergh RC, Bangma CH et al. A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer. Eur Urol 2010; 57: 79\u201385.","journal-title":"Eur Urol"},{"key":"BFpcan201162_CR16","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1002\/1097-0142(19930315)71:6<2031::AID-CNCR2820710618>3.0.CO;2-Q","volume":"71","author":"HP Schmid","year":"1993","unstructured":"Schmid HP, McNeal JE, Stamey TA . Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume. Cancer 1993; 71: 2031\u20132040.","journal-title":"Cancer"},{"key":"BFpcan201162_CR17","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.1996.03530280040034","volume":"275","author":"JA Dugan","year":"1996","unstructured":"Dugan JA, Bostwick DG, Myers RP, Qian J, Bergstralh EJ, Oesterling JE . The definition and preoperative prediction of clinically insignificant prostate cancer. JAMA 1996; 275: 288\u2013294.","journal-title":"JAMA"},{"key":"BFpcan201162_CR18","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/S0090-4295(00)00613-0","volume":"56","author":"K Ito","year":"2000","unstructured":"Ito K, Yamamoto T, Kubota Y, Suzuki K, Fukabori Y, Kurokawa K et al. Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer. Urology 2000; 56: 278\u2013282.","journal-title":"Urology"},{"key":"BFpcan201162_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0022-5347(01)65322-9","volume":"157","author":"LA Eskew","year":"1997","unstructured":"Eskew LA, Bare RL, McCullough DL . Systematic 5 region biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997; 157: 199\u2013202.","journal-title":"J Urol"},{"key":"BFpcan201162_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0022-5347(05)67995-5","volume":"163","author":"JC Presti","year":"2000","unstructured":"Presti JC, Chang JJ, Bhargava V, Shinohara K . The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol 2000; 163: 163\u2013167.","journal-title":"J Urol"},{"key":"BFpcan201162_CR21","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/S0022-5347(05)66347-1","volume":"165","author":"JL Gore","year":"2001","unstructured":"Gore JL, Shariat SF, Miles BJ, Kadmon D, Jiang N, Wheeler TM et al. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol 2001; 165: 1554\u20131559.","journal-title":"J Urol"},{"key":"BFpcan201162_CR22","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.eururo.2007.02.062","volume":"52","author":"G Guichard","year":"2007","unstructured":"Guichard G, Larre S, Gallina A, Lazar A, Faucon H, Chemama S et al. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients. Eur Urol 2007; 52: 430\u2013435.","journal-title":"Eur Urol"},{"key":"BFpcan201162_CR23","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.eururo.2010.08.041","volume":"58","author":"FK Chun","year":"2010","unstructured":"Chun FK, Epstein JI, Ficarra V, Freedland SJ, Montironi R, Montorsi F et al. Optimizing performance and interpretation of prostate biopsy: a critical analysis of the literature. Eur Urol 2010; 58: 851\u2013864.","journal-title":"Eur Urol"},{"key":"BFpcan201162_CR24","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S0090-4295(99)80353-7","volume":"46","author":"RG Uzzo","year":"1995","unstructured":"Uzzo RG, Wei JT, Waldbaum RS, Perlmutter AP, Byrne JC, Vaughan Jr ED . The influence of prostate size on cancer detection. Urology 1995; 46: 831\u2013836.","journal-title":"Urology"},{"key":"BFpcan201162_CR25","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/S0090-4295(03)00108-0","volume":"61","author":"A de la Taille","year":"2003","unstructured":"de la Taille A, Antiphon P, Salomon L, Cherfan M, Porcher R, Hoznek A et al. Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate. Urology 2003; 61: 1181\u20131186.","journal-title":"Urology"},{"key":"BFpcan201162_CR26","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.juro.2007.11.052","volume":"179","author":"V Scattoni","year":"2008","unstructured":"Scattoni V, Roscigno M, Raber M, Deh\u00f2 F, Maga T, Zanoni M et al. Initial extended transrectal prostate biopsy\u2014are more prostate cancers detected with 18 cores than 12 cores? J Urol 2008; 179: 1327\u20131331.","journal-title":"J Urol"},{"key":"BFpcan201162_CR27","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1097\/01.ju.0000173924.83392.cc","volume":"174","author":"M Remzi","year":"2005","unstructured":"Remzi M, Fong YK, Dobrovits M, Anagnostou T, Seitz C, Waldert M et al. The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volumes. J Urol 2005; 174: 1256\u20131261.","journal-title":"J Urol"},{"key":"BFpcan201162_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1089\/end.2009.0285","volume":"24","author":"J Jiang","year":"2010","unstructured":"Jiang J, Colli J, El-Galley R . A simple method for estimating the optimal number of prostate biopsy cores needed to maintain high cancer detection rates while minimizing unnecessary biopsy sampling. J Endourol 2010; 24: 143\u2013147.","journal-title":"J Endourol"},{"key":"BFpcan201162_CR29","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/S0090-4295(98)00366-5","volume":"52","author":"TJ Bassler","year":"1998","unstructured":"Bassler TJ, Orozco R, Bassler GJ, O\u2019Dowd GJ, Stamey TA . Most prostate cancers missed by raising the upper limit of normal prostate-specific antigen for men in their sixties are clinically significant. Urology 1998; 52: 1064\u20131069.","journal-title":"Urology"},{"key":"BFpcan201162_CR30","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1442-2042.2010.02453.x","volume":"17","author":"T Ohigashi","year":"2010","unstructured":"Ohigashi T, Kanao K, Mizuno R, Kikuchi E, Nakashima J, Oya M . Predicting the probability of significant prostate cancer in Japanese men with serum prostate-specific antigen less than 10\u2009ng\/ml: development of a novel pre-biopsy nomogram. Int J Urol 2010; 17: 274\u2013280.","journal-title":"Int J Urol"},{"key":"BFpcan201162_CR31","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1442-2042.2009.02304.x","volume":"16","author":"M Miyakubo","year":"2009","unstructured":"Miyakubo M, Ito K, Yamamoto T, Takechi H, Ohi M, Suzuki K . Prostate-specific antigen: its usefulness in the era of multiple-core prostate biopsy. Int J Urol 2009; 16: 561\u2013565.","journal-title":"Int J Urol"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/pcan201162.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/pcan201162","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/pcan201162.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T21:29:17Z","timestamp":1648675757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pcan201162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,6]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["BFpcan201162"],"URL":"https:\/\/doi.org\/10.1038\/pcan.2011.62","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,6]]},"assertion":[{"value":"13 June 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}